European Patent Application EP4263836A1, titled 'Immunocytokines and Uses Thereof,' was published by the European Patent Office (EPO) on March 11, 2026. The application was filed by Immunowake Inc. and lists WU, Ellen, WU, Xiaoyun, and WAKEFIELD, John as inventors. The patent covers immunocytokines, which are fusion proteins combining immune-stimulating cytokines with antibodies, and their therapeutic applications, particularly in cancer treatment.

This publication represents the grant of a patent, not a regulatory rule or guidance with direct compliance obligations for most entities. However, it signifies new intellectual property in the field of biopharmaceuticals. Companies operating in the biotechnology and pharmaceutical sectors, particularly those involved in cancer immunotherapy research and development, should be aware of this patent. Legal and R&D departments should review the patent's claims to assess potential impacts on their own research, development, and commercialization strategies, especially concerning immunocytokine-based therapies.